These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 31196103)
21. Clinical and endocrine characteristics and genetic analysis of Korean children with McCune-Albright syndrome: a retrospective cohort study. Cho EK; Kim J; Yang A; Ki CS; Lee JE; Cho SY; Jin DK Orphanet J Rare Dis; 2016 Aug; 11(1):113. PubMed ID: 27506760 [TBL] [Abstract][Full Text] [Related]
22. Hypothyroidism in McCune-Albright Syndrome and Role of Bone Scan in Management of Fibrous Dysplasia: An Unusual Case Scenario with Review of Literature. Kumar N; Kheruka SC; Singh RK; Ravina M; Dutta D; Gambhir S Indian J Nucl Med; 2017; 32(1):25-29. PubMed ID: 28242980 [TBL] [Abstract][Full Text] [Related]
23. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia. Lietman SA; Ding C; Levine MA J Bone Joint Surg Am; 2005 Nov; 87(11):2489-94. PubMed ID: 16264125 [TBL] [Abstract][Full Text] [Related]
25. Fibrous Dysplasia/McCune-Albright Syndrome: A Rare, Mosaic Disease of Gα s Activation. Boyce AM; Collins MT Endocr Rev; 2020 Apr; 41(2):345-70. PubMed ID: 31673695 [TBL] [Abstract][Full Text] [Related]
26. PET Imaging of Phosphodiesterase-4 Identifies Affected Dysplastic Bone in McCune-Albright Syndrome, a Genetic Mosaic Disorder. Weidner LD; Wakabayashi Y; Stolz LA; Collins MT; Guthrie L; Victorino M; Chung J; Miller W; Zoghbi SS; Pike VW; Fujita M; Innis RB; Boyce AM J Nucl Med; 2020 Nov; 61(11):1672-1677. PubMed ID: 32284396 [TBL] [Abstract][Full Text] [Related]
27. DIAGNOSIS OF ENDOCRINE DISEASE: Mosaic disorders of FGF23 excess: Fibrous dysplasia/McCune-Albright syndrome and cutaneous skeletal hypophosphatemia syndrome. de Castro LF; Ovejero D; Boyce AM Eur J Endocrinol; 2020 May; 182(5):R83-R99. PubMed ID: 32069220 [TBL] [Abstract][Full Text] [Related]
28. Natural History and Progression of Craniofacial Fibrous Dysplasia: A Retrospective Evaluation of 114 Patients From Massachusetts General Hospital. Sweeney K; Kaban LB J Oral Maxillofac Surg; 2020 Nov; 78(11):1966-1980. PubMed ID: 32619461 [TBL] [Abstract][Full Text] [Related]
29. The Clinical Spectrum of McCune-Albright Syndrome and Its Management. Spencer T; Pan KS; Collins MT; Boyce AM Horm Res Paediatr; 2019; 92(6):347-356. PubMed ID: 31865341 [TBL] [Abstract][Full Text] [Related]
30. Correction to: Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium. Javaid MK; Boyce A; Appelman-Dijkstra N; Ong J; Defabianis P; Offiah A; Arundel P; Shaw N; Pos VD; Underhil A; Portero D; Heral L; Heegaard AM; Masi L; Monsell F; Stanton R; Dijkstra PDS; Brandi ML; Chapurlat R; Hamdy NAT; Collins MT Orphanet J Rare Dis; 2019 Nov; 14(1):267. PubMed ID: 31752972 [TBL] [Abstract][Full Text] [Related]
31. A novel technique based on a PNA hybridization probe and FRET principle for quantification of mutant genotype in fibrous dysplasia/McCune-Albright syndrome. Karadag A; Riminucci M; Bianco P; Cherman N; Kuznetsov SA; Nguyen N; Collins MT; Robey PG; Fisher LW Nucleic Acids Res; 2004 Apr; 32(7):e63. PubMed ID: 15096559 [TBL] [Abstract][Full Text] [Related]
32. Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune-Albright Syndrome. van der Bruggen W; Vriens D; Meier ME; Smit F; Winter EM; de Geus-Oei LF; Appelman-Dijkstra NM J Clin Endocrinol Metab; 2021 Jul; 106(8):e2980-e2994. PubMed ID: 33788944 [TBL] [Abstract][Full Text] [Related]
33. Coxa Vara Deformity in Fibrous Dysplasia/McCune-Albright Syndrome: Prevalence, Natural History and Risk Factors: A Two-Center Study. Meier ME; Appelman-Dijkstra NM; Collins MT; Geels RES; Stanton RP; de Witte PB; Boyce AM; van de Sande MAJ J Bone Miner Res; 2023 Jul; 38(7):968-975. PubMed ID: 37102469 [TBL] [Abstract][Full Text] [Related]
34. Lesion Expansion in Gnathic Fibrous Dysplasia: Natural History, Indicators of Progression, and Response to Bisphosphonates. Pan KS; Taylor J; Szymczuk V; Boyce AM J Bone Miner Res; 2023 Oct; 38(10):1465-1471. PubMed ID: 37477421 [TBL] [Abstract][Full Text] [Related]
36. Long Bone Fractures in Fibrous Dysplasia/McCune-Albright Syndrome: Prevalence, Natural History, and Risk Factors. Geels RES; Meier ME; Saikali A; Tsonaka R; Appelman-Dijkstra NM; Boyce AM J Bone Miner Res; 2022 Feb; 37(2):236-243. PubMed ID: 34668234 [TBL] [Abstract][Full Text] [Related]
37. Denosumab use in bone fibrous dysplasia refractory to bisphosphonate: A retrospective multicentric study. Trojani MC; Gensburger D; Bagouet F; Cortet B; Couture G; Marcelli C; Mehsen Cetre N; Breuil V; Chapurlat R Bone; 2023 Sep; 174():116819. PubMed ID: 37301527 [TBL] [Abstract][Full Text] [Related]
38. Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia. Kobayashi K; Imanishi Y; Koshiyama H; Miyauchi A; Wakasa K; Kawata T; Goto H; Ohashi H; Koyano HM; Mochizuki R; Miki T; Inaba M; Nishizawa Y Life Sci; 2006 Apr; 78(20):2295-301. PubMed ID: 16337659 [TBL] [Abstract][Full Text] [Related]
39. Advances in Models of Fibrous Dysplasia/McCune-Albright Syndrome. Lung H; Hsiao EC; Wentworth KL Front Endocrinol (Lausanne); 2019; 10():925. PubMed ID: 32038487 [TBL] [Abstract][Full Text] [Related]
40. Clinical and radiological observations in a case series of 26 patients with fibrous dysplasia. Thomsen MD; Rejnmark L Calcif Tissue Int; 2014 Apr; 94(4):384-95. PubMed ID: 24390518 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]